Skip to search.
 BSE Down 0.19% NSE Down 0.23%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
5.26 Up 0.09(1.74%) 27 Aug 1:30am
|After Hours : 5.26 Up 0.00 (0.02%) 27 Aug 2:32am
Prev Close:5.17
Open:5.12
Bid:5.23 x 100
Ask:5.26 x 1000
1y Target Est:13.00
Beta:1.91351
Earnings Date:31 Oct - 4 Nov (Est.)
Day's Range:5.10 - 5.40
52wk Range:4.45 - 14.93
Volume:1,453,449
Avg Vol (3m):2,266,110
Market Cap:686.41M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPUp 1.74%686.41M
IMGNUp 0.69%254.26M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):90.51
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.34
Quarterly EPS Est (Sep-16) :-0.11
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback